Nikita Hiren Patel reduced her shareholding in Bacil Pharma Limited by 7.1% through an open-market disposal of shares on June 22 and June 23, 2026. The transaction was disclosed to the Bombay Stock Exchange Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Prior to the disposal, Patel held 24,63,896 shares, representing 17.17% of the total voting capital. The sale of 10,19,052 shares reduced her total holding to 14,44,844 shares, which constitutes 10.07% of the company's voting capital. Bacil Pharma's total equity share capital remains unchanged at 1,43,53,000 equity shares of ₹10 each.

The disclosure confirmed that the acquirer does not belong to the promoter or promoter group of the target company. The total diluted share capital of the company was reported as NA following the transaction. The filing was submitted by Mrs. Nikita Hiren Patel as the authorised signatory.

Shareholding Details

The following table outlines the changes in Patel's shareholding:

The mode of sale was specified as open-market transactions. The equity share capital of Bacil Pharma Limited before and after the disposal stood at 1,43,53,000 equity shares.

Bacil Pharma Limited has scheduled a board meeting for June 26, 2026, to evaluate proposals for raising funds through one or more permissible modes. The meeting will be held at the company's registered office in Mumbai to consider financial strategies subject to statutory and regulatory approvals.

The board will assess options including a preferential issue, which may involve the allotment of equity shares and/or convertible securities, and a rights issue. Other permissible modes or combinations thereof may also be considered in accordance with the Companies Act, 2013, and relevant SEBI regulations, including the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

In conjunction with the meeting, the company has announced the closure of its trading window for all designated persons and their immediate relatives. This measure is effective immediately and will remain in place until 48 hours after the declaration of the board meeting's outcome, in compliance with the company's Code of Conduct for Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The board may also consider any other business placed before it with the permission of the Chairman. The outcome of the meeting will be communicated to the stock exchanges in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Agenda Items